200 related articles for article (PubMed ID: 18461147)
1. Identification and characterization of cancer initiating cells from BRCA1 related mammary tumors using markers for normal mammary stem cells.
Vassilopoulos A; Wang RH; Petrovas C; Ambrozak D; Koup R; Deng CX
Int J Biol Sci; 2008 May; 4(3):133-42. PubMed ID: 18461147
[TBL] [Abstract][Full Text] [Related]
2. A critical role of CD29 and CD49f in mediating metastasis for cancer-initiating cells isolated from a Brca1-associated mouse model of breast cancer.
Vassilopoulos A; Chisholm C; Lahusen T; Zheng H; Deng CX
Oncogene; 2014 Nov; 33(47):5477-82. PubMed ID: 24317509
[TBL] [Abstract][Full Text] [Related]
3. Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics.
Wright MH; Calcagno AM; Salcido CD; Carlson MD; Ambudkar SV; Varticovski L
Breast Cancer Res; 2008; 10(1):R10. PubMed ID: 18241344
[TBL] [Abstract][Full Text] [Related]
4. Dietary suppression of the mammary CD29(hi)CD24(+) epithelial subpopulation and its cytokine/chemokine transcriptional signatures modifies mammary tumor risk in MMTV-Wnt1 transgenic mice.
Rahal OM; Machado HL; Montales MT; Pabona JM; Heard ME; Nagarajan S; Simmen RC
Stem Cell Res; 2013 Nov; 11(3):1149-62. PubMed ID: 24012543
[TBL] [Abstract][Full Text] [Related]
5. ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells.
Leccia F; Del Vecchio L; Mariotti E; Di Noto R; Morel AP; Puisieux A; Salvatore F; Ansieau S
Mol Cancer; 2014 Sep; 13():213. PubMed ID: 25216750
[TBL] [Abstract][Full Text] [Related]
6. Notch-1 signaling promotes the cyclinD1-dependent generation of mammary tumor-initiating cells that can revert to bi-potential progenitors from which they arise.
Ling H; Jolicoeur P
Oncogene; 2013 Jul; 32(29):3410-9. PubMed ID: 22907433
[TBL] [Abstract][Full Text] [Related]
7. Alpha-6 integrin deletion delays the formation of Brca1/p53-deficient basal-like breast tumors by restricting luminal progenitor cell expansion.
Faraldo MM; Romagnoli M; Wallon L; Dubus P; Deugnier MA; Fre S
Breast Cancer Res; 2024 Jun; 26(1):91. PubMed ID: 38835038
[TBL] [Abstract][Full Text] [Related]
8. Separation by cell size enriches for mammary stem cell repopulation activity.
Machado HL; Kittrell FS; Edwards D; White AN; Atkinson RL; Rosen JM; Medina D; Lewis MT
Stem Cells Transl Med; 2013 Mar; 2(3):199-203. PubMed ID: 23408103
[TBL] [Abstract][Full Text] [Related]
9. Identification of tumor-initiating cells in a p53-null mouse model of breast cancer.
Zhang M; Behbod F; Atkinson RL; Landis MD; Kittrell F; Edwards D; Medina D; Tsimelzon A; Hilsenbeck S; Green JE; Michalowska AM; Rosen JM
Cancer Res; 2008 Jun; 68(12):4674-82. PubMed ID: 18559513
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a multipotent mammary progenitor with pregnancy-specific activity.
Kaanta AS; Virtanen C; Selfors LM; Brugge JS; Neel BG
Breast Cancer Res; 2013; 15(4):R65. PubMed ID: 23947835
[TBL] [Abstract][Full Text] [Related]
11. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ
Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473
[TBL] [Abstract][Full Text] [Related]
12. Novel measurements of mammary stem cells in human umbilical cord blood as prospective predictors of breast cancer susceptibility in later life.
Qiu L; Low HP; Chang CI; Strohsnitter WC; Anderson M; Edmiston K; Adami HO; Ekbom A; Hall P; Lagiou P; Trichopoulos D; Hsieh CC
Ann Oncol; 2012 Jan; 23(1):245-250. PubMed ID: 21515664
[TBL] [Abstract][Full Text] [Related]
13. CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells.
Pruszak J; Ludwig W; Blak A; Alavian K; Isacson O
Stem Cells; 2009 Dec; 27(12):2928-40. PubMed ID: 19725119
[TBL] [Abstract][Full Text] [Related]
14. Evidence that aberrant expression of tissue transglutaminase promotes stem cell characteristics in mammary epithelial cells.
Kumar A; Gao H; Xu J; Reuben J; Yu D; Mehta K
PLoS One; 2011; 6(6):e20701. PubMed ID: 21687668
[TBL] [Abstract][Full Text] [Related]
15. RARα1 control of mammary gland ductal morphogenesis and wnt1-tumorigenesis.
Cohn E; Ossowski L; Bertran S; Marzan C; Farias EF
Breast Cancer Res; 2010; 12(5):R79. PubMed ID: 20923554
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line.
Rappa G; Lorico A
Exp Cell Res; 2010 May; 316(9):1576-86. PubMed ID: 20074564
[TBL] [Abstract][Full Text] [Related]
17. Dissecting the heterogeneity and tumorigenesis of BRCA1 deficient mammary tumors via single cell RNA sequencing.
Sun H; Zeng J; Miao Z; Lei KC; Huang C; Hu L; Su SM; Chan UI; Miao K; Zhang X; Zhang A; Guo S; Chen S; Meng Y; Deng M; Hao W; Lei H; Lin Y; Yang Z; Tang D; Wong KH; Zhang XD; Xu X; Deng CX
Theranostics; 2021; 11(20):9967-9987. PubMed ID: 34815798
[No Abstract] [Full Text] [Related]
18. Progesterone receptor A stability is mediated by glycogen synthase kinase-3β in the Brca1-deficient mammary gland.
Wang S; Li Y; Hsu PH; Lee SY; Kim Y; Lee EYP
J Biol Chem; 2013 Sep; 288(36):26265-26274. PubMed ID: 23880761
[TBL] [Abstract][Full Text] [Related]
19. BRCA1-IRIS overexpression promotes and maintains the tumor initiating phenotype: implications for triple negative breast cancer early lesions.
Sinha A; Paul BT; Sullivan LM; Sims H; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
Oncotarget; 2017 Feb; 8(6):10114-10135. PubMed ID: 28052035
[TBL] [Abstract][Full Text] [Related]
20. Tumor-initiating cells are not enriched in cisplatin-surviving BRCA1;p53-deficient mammary tumor cells in vivo.
Pajic M; Kersbergen A; van Diepen F; Pfauth A; Jonkers J; Borst P; Rottenberg S
Cell Cycle; 2010 Sep; 9(18):3780-91. PubMed ID: 20855963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]